UK markets close in 4 hours 58 minutes

GenSight Biologics S.A. (SIGHTP.XC)

Cboe UK - Cboe UK Real-time price. Currency in EUR
Add to watchlist
0.5400-0.0130 (-2.35%)
As of 04:29PM BST. Market open.
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
2,134
10,610
44,288
37,943
-
Total cash
2,134
10,610
44,288
37,943
-
Net receivables
1
0
754
52
-
Other current assets
47
365
412
642
-
Total current assets
6,529
22,947
53,363
43,759
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
6,161
6,896
6,136
5,786
-
Accumulated depreciation
-4,136
-4,628
-3,587
-2,632
-
Net property, plant and equipment
2,025
2,268
2,549
3,154
-
Intangible assets
75
93
112
133
-
Other long-term assets
1
1
-
-
-
Total non-current assets
2,603
2,994
3,285
3,602
-
Total assets
9,132
25,941
56,648
47,361
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
16,605
1,535
4,675
2,405
-
Accounts payable
5,634
7,813
11,561
7,588
-
Other current liabilities
395
671
-
3
4
Total current liabilities
25,290
14,642
22,242
17,123
-
Non-current liabilities
Long-term debt
0
9,246
5,644
9,440
-
Deferred revenues
0
193
420
-
-
Other long-term liabilities
5,073
5,288
5,282
6,973
-
Total non-current liabilities
14,510
26,652
18,416
18,489
-
Total liabilities
39,800
41,294
40,658
35,612
-
Stockholders' equity
Common stock
1,633
1,158
1,158
1,022
-
Retained earnings
-26,220
-27,625
-28,617
-34,015
-
Total stockholders' equity
-30,668
-15,353
15,990
11,749
-
Total liabilities and stockholders' equity
9,132
25,941
56,648
47,361
-